These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 4615298)

  • 1. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
    Wierup M
    Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cotrimoxazole resistance of Escherichia coli].
    Digranes A; Madsen ST
    Tidsskr Nor Laegeforen; 1979 Feb; 99(3):168, 156. PubMed ID: 369032
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergy of trimethoprim-sulfamethoxazole.
    Bushby SR
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):63-6. PubMed ID: 1093654
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 11. The carriage of Escherichia coli on the peri-urethral area and in the feces in patients on long term low dose cotrimoxazole therapy.
    Cattell WR; McSherry MA; Brooks HL; O'Grady FW
    Clin Nephrol; 1976 Dec; 6(6):506-8. PubMed ID: 795583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Staphylococcus aureus to sulphametoxazol-trimethoprim (author's transl).
    Herrera R; Sanles C
    Rev Med Chil; 1974 Dec; 102(12):927-30. PubMed ID: 4463435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
    Knothe H
    Arzneimittelforschung; 1973 May; 23(5):704-8. PubMed ID: 4197002
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals.
    Ho PL; Wong RC; Chow KH; Que TL
    Lett Appl Microbiol; 2009 Nov; 49(5):627-34. PubMed ID: 19780962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibacterial effect of sulfanilamide combination drugs].
    Metz H; Preac-Mursic V
    Med Klin; 1972 Dec; 67(49):1626-31. PubMed ID: 4566636
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole. I. Description.
    Wormser GP
    N Y State J Med; 1978 Oct; 78(12):1915-21. PubMed ID: 360112
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to co-trimoxazole.
    McAllister TA
    Scand J Infect Dis Suppl; 1976; (8):29-38. PubMed ID: 1084551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative susceptibility testing to sulfamethoxazole and trimethoprim by agar diffusion test on different media (author's transl)].
    Freiesleben H; Marre R
    Immun Infekt; 1978 Dec; 6(6):223-5. PubMed ID: 365716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.